Sipuleucel T
917381-47-6 Basic informationMore
- Product Name:Sipuleucel T
- Synonyms: Sipuleucel T
- CAS:917381-47-6
- MF:
- MW:0
- EINECS:
- Mol File:Mol File
-
USE
Sipuleucel-T is the first FDA-approved therapeutic cancer vaccine. It
is approved for the treatment of asymptomatic or minimally symptomatic
metastatic castration-resistant (hormone-refractory) prostate cancer.
Sipuleucel-T is described as a therapy rather than a precisely defined
therapeutic agent because it is an autologous vaccine that is generated
from each individual patient's own blood cells.
Browse by Nationality 917381-47-6 Suppliers >Global suppliers
Shanghai (1) Hubei (2) Shaanxi (1) Member (4) All (4)
Please select the suppliers
Recommend You Select Member Companies
Recommend You Select Member Companies
- Company Name:Pushan Industry (Shaanxi) Co., Ltd.
- Tel:029-81310890 13571859809
- Products Intro:Product Name:Sipuleucel T
CAS:917381-47-6
Purity:99 - CB Index:58
- Related Information:Catalog(10009)